Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
human
taxon 9606Not yet assessed
Occurrence records: Recorded mostly outside Africa. 344 of 24,908 GBIF records (1%) are from Africa (checked 10/9/2026). A hint from GBIF and the genomes on this Hub, not an assessment: GBIF includes zoo and travel records.
Species that share this one's nearest groups in NCBI Taxonomy. This is how they're classified, not a phylogeny. See it in the species tree.
The assembly file for Homo sapiens hasn't finished reaching the Hub yet — check back shortly.
Origin: hub
0 downloads
First synced: 9/1/2026 · Last updated: 9/1/2026
Source: NCBI GCA_003086635.1 · View at source ↗
Collection: Sierra Leone · Sex: female
Sequencing: PacBio Sequel · FALCON-integrate v. 1.7.5 · 68.12x coverage
Released: 2018-05-02 · Submitted by: The Genome Institute at Washington University School of Medicine
publiccc0AFDSI-SEQ-788 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: SL · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 3.03 Gb · scaffold N50 71,205,264 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 9/1/2026 · Last updated: 9/1/2026
Source: NCBI GCA_003574075.1 · View at source ↗
Collection: Gambia: Western Division · Sex: female
Sequencing: PacBio · Falcon v. integrate.1.7.5 · 86.84x coverage
Released: 2018-09-18 · Submitted by: The Genome Institute at Washington University School of Medicine
publiccc0AFDSI-SEQ-796 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: GM · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 3.03 Gb · scaffold N50 71,205,264 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 9/1/2026 · Last updated: 9/1/2026
Source: NCBI GCA_003709695.1 · View at source ↗
Collection: Gambia: Western Division · Sex: female
Sequencing: PacBio · Celera Assembler v. 8.3rc2 · 98x coverage
Released: 2018-11-02 · Submitted by: University of Washington
publiccc0AFDSI-SEQ-799 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: GM · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 3.03 Gb · scaffold N50 71,205,264 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 9/1/2026 · Last updated: 9/1/2026
Source: NCBI GCA_003709735.1 · View at source ↗
Collection: Kenya: Webuye · Sex: female
Sequencing: PacBio · Celera Assembler v. 8.3rc2 · 71x coverage
Released: 2018-11-02 · Submitted by: University of Washington
publiccc0AFDSI-SEQ-800 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: KE · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 3.03 Gb · scaffold N50 71,205,264 · View at source ↗
Publicly accessible — no request needed.
Origin: hub
0 downloads
First synced: 9/1/2026 · Last updated: 9/1/2026
Source: NCBI GCA_002872155.1 · View at source ↗
Collection: Kenya: Webuye · Sex: female
Sequencing: PacBio RSII · FALCON-integrate v. 1.7.5 · 73x coverage
Released: 2018-01-10 · Submitted by: The Genome Institute at Washington University School of Medicine
publiccc0AFDSI-SEQ-782 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: KE · PIC: unknown · MAT: unknown
GoaT: Contig assembly · 3.03 Gb · scaffold N50 71,205,264 · View at source ↗
Publicly accessible — no request needed.
MT-RNR1 — 16 aa
CIROP — 788 aa
BLTP3B — 1464 aa
POTEB3 — 581 aa
CLRN2 — 232 aa
ARHGAP10 — 786 aa
FAM170A — 330 aa
SYCE3 — 88 aa
ELOVL7 — 281 aa
SH3PXD2B — 911 aa
Origin: hub
0 downloads
First synced: 9/2/2026 · Last updated: 9/2/2026
Source: NCBI PZ620301.1 · View at source ↗
Collection: USA: Washington, King County
Released: 2026-08-30
publiccc0AFDSI-SEQ-969 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: US · PIC: unknown · MAT: unknown
Publicly accessible — no request needed.
AlphaFold DB proteome: UP000005640 ↗
PaxDb — real per-protein abundance
TMSB4X (9606.ENSP00000370010) — abundance 82964AFDSI-PROTEOMICS-551
APOA2 (9606.ENSP00000356969) — abundance 31361AFDSI-PROTEOMICS-552
RBP4 (9606.ENSP00000360522) — abundance 24443AFDSI-PROTEOMICS-553
ORM1 (9606.ENSP00000259396) — abundance 22835AFDSI-PROTEOMICS-554
APOA1 (9606.ENSP00000236850) — abundance 20723AFDSI-PROTEOMICS-555
ALB (9606.ENSP00000295897) — abundance 19929AFDSI-PROTEOMICS-556
TTR (9606.ENSP00000237014) — abundance 19096AFDSI-PROTEOMICS-557
APOC2 (9606.ENSP00000466775) — abundance 17564AFDSI-PROTEOMICS-558
APOC1 (9606.ENSP00000465356) — abundance 16749AFDSI-PROTEOMICS-559
HPX (9606.ENSP00000265983) — abundance 15511AFDSI-PROTEOMICS-560
PRIDE — project-level reference (metadata only; no per-protein identifications are available via PRIDE's public API)
Proteomic profiling of septal myocardium in hypertrophic cardiomyopathy (PXD083434) ↗AFDSI-PROJREF-382
Motile Vesicles or MoVes are a migration-associated extracellular vesicle population carrying genomic DNA (PXD083320) ↗AFDSI-PROJREF-383
Investigating N-terminal shedding of GPR125 in GPR125 overexpressing HEK293T cells using N- and C-terminal enrichment and different cleavage strategies (PXD083139) ↗AFDSI-PROJREF-385
Activity-based profiling of primary brain cells identifies covalent allosteric modulators of HCN channels (PXD082934) ↗AFDSI-PROJREF-387
A two-exon deletion and hypomorphic missense variant in GEMIN5 causes autosomal recessive ataxia (PXD082880) ↗AFDSI-PROJREF-389
ChEMBL rows are compounds active against a protein target from this organism — not confirmed as compounds the species itself produces, unlike ANPDB's.
ChEMBL: CHEMBL3084806 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 4200.0 nMAFDSI-METABOLOMICS-959
ChEMBL: CHEMBL86578 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 93.0 nMAFDSI-METABOLOMICS-984
ChEMBL: CHEMBL2114210 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 110000.0 nMAFDSI-METABOLOMICS-949
ChEMBL: CHEMBL87169 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 700.0 nMAFDSI-METABOLOMICS-950
ChEMBL: CHEMBL2115215 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3200.0 nMAFDSI-METABOLOMICS-951
ChEMBL: CHEMBL501355 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 40.0 nMAFDSI-METABOLOMICS-952
ChEMBL: CHEMBL2115215 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3200.0 nMAFDSI-METABOLOMICS-953
ChEMBL: CHEMBL2093897 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 8400.0 nMAFDSI-METABOLOMICS-954
ChEMBL: CHEMBL2093897 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 8400.0 nM
MetaboLights: N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression (View at source ↗)AFDSI-METABPROF-139
MetaboLights: Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer (View at source ↗)AFDSI-METABPROF-140
MetaboLights: Metabolic profiling reveals CAD as a central metabolic signaling node (View at source ↗)AFDSI-METABPROF-141
MetaboLights: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type-2 diabetes (View at source ↗)AFDSI-METABPROF-142
MetaboLights: Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays) (View at source ↗)AFDSI-METABPROF-143
MetaboLights: In-depth organic mass cytometry reveals differential contents of 3-hydroxybutanoic acid at the single-cell level (View at source ↗)AFDSI-METABPROF-180
KEGG: KEGG genome-based metabolic profile (hsa) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-155
pLDDT confidence: unknown · ligands: 2-acetamido-2-deoxy-beta-D-glucopyranose, (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE, (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE, CHOLESTEROL HEMISUCCINATE
Auto-synced from PDBe 6xiw · View at source ↗
publiccc_byAFDSI-STRUCT-12537-V4pLDDT confidence: unknown · ligands: MAGNESIUM ION, ADP ORTHOVANADATE
Auto-synced from PDBe 4byf · View at source ↗
publiccc_byAFDSI-STRUCT-12541-V4pLDDT confidence: unknown · ligands: 2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose
Auto-synced from PDBe 4iop · View at source ↗
publiccc_byAFDSI-STRUCT-12539-V4pLDDT confidence: unknown · ligands: ZINC ION
Auto-synced from PDBe 9rwz · View at source ↗
publiccc_byAFDSI-STRUCT-12535-V4pLDDT confidence: unknown · ligands: ZINC ION, MAGNESIUM ION, IRON/SULFUR CLUSTER, GUANOSINE-5'-TRIPHOSPHATE
Auto-synced from PDBe 9k3u · View at source ↗
publiccc_byAFDSI-STRUCT-12527-V3camera_trap at Senegal · Source: GBIF 5015494015 (View at source ↗)AFDSI-IMG-15447
camera_trap at Rwanda · Source: GBIF 6195104371 (View at source ↗)AFDSI-IMG-15339
camera_trap at Rwanda · Source: GBIF 6195114282 (View at source ↗)AFDSI-IMG-15340
camera_trap at Rwanda · Source: GBIF 6195117939 (View at source ↗)AFDSI-IMG-15341
camera_trap at Egypt · Source: GBIF 6181738505 (View at source ↗)AFDSI-IMG-15342
camera_trap at Madagascar · Source: GBIF 5937970537 (View at source ↗)AFDSI-IMG-15343
camera_trap at Senegal · Source: GBIF 5017189636 (View at source ↗)AFDSI-IMG-15448
camera_trap at Gambia · Source: GBIF 5025526855 (View at source ↗)AFDSI-IMG-15449
camera_trap at Spain · Source: GBIF 5014524674 (View at source ↗)AFDSI-IMG-15450
camera_trap at Spain · Source: GBIF 5135578858 (View at source ↗)AFDSI-IMG-15451
BioImage Archive: MitoEM 2.0 - A Benchmark for Challenging 3D Mitochondria Instance Segmentation from EM Images (View on source archive ↗)AFDSI-CELL-912
BioImage Archive: (View on source archive ↗)AFDSI-CELL-903
BioImage Archive: Benchmarking porcine pancreatic ductal organoids for drug screening applications (View on source archive ↗)AFDSI-CELL-904
BioImage Archive: Focal adhesions are controlled by microtubules through local contractility regulation (View on source archive ↗)AFDSI-CELL-905
BioImage Archive: Synthetic protein binders reveal a cryptic regulatory pocket on Aurora A for selective allosteric inhibition (View on source archive ↗)AFDSI-CELL-906
BioImage Archive: Source Data for the Images (View on source archive ↗)AFDSI-CELL-907
BioImage Archive: (View on source archive ↗)AFDSI-CELL-908
BioImage Archive: EMBO Reports revision image source data (View on source archive ↗)AFDSI-CELL-909
BioImage Archive: ST Profiling Reveals Distinct Tumor Microenvironment Dynamics in Cervical Adenocarcinoma and Squamous Cell Carcinoma (View on source archive ↗)AFDSI-CELL-910
BioImage Archive: 11111111111111111111111111111111 (View on source archive ↗)AFDSI-CELL-911
344 real GBIF-recorded occurrences across Africa — see this species on GBIF ↗.
This reflects real occurrence records submitted to GBIF, not a comprehensive range map — sampling effort varies significantly by country and region, so an absence here doesn't mean the species isn't present.
A node's own derived bioinformatics-analysis output (e.g. an SSR/microsatellite discovery archive) run against this species' own genome data — see the Derived Analysis page for the full catalog.
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-800
File: GCA_003709735.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P web pipeline)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-21262MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-799
File: GCA_003709695.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P web pipeline)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-21261ChEMBL: CHEMBL2442258 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 60.0 nMAFDSI-METABOLOMICS-956
ChEMBL: CHEMBL2442258 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 60.0 nMAFDSI-METABOLOMICS-957
ChEMBL: CHEMBL3084806 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 4200.0 nMAFDSI-METABOLOMICS-958
ChEMBL: PINACIDIL ANHYDROUS (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 3540.0 nMAFDSI-METABOLOMICS-960
ChEMBL: CHEMBL11458 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 230.0 nMAFDSI-METABOLOMICS-962
ChEMBL: CROMAKALIM (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 1250.0 nMAFDSI-METABOLOMICS-966
ChEMBL: PINACIDIL ANHYDROUS (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 3540.0 nMAFDSI-METABOLOMICS-961
ChEMBL: CHEMBL11458 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 230.0 nMAFDSI-METABOLOMICS-963
ChEMBL: CROMAKALIM (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 1250.0 nMAFDSI-METABOLOMICS-964
ChEMBL: CHEMBL454369 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 310.0 nMAFDSI-METABOLOMICS-965
ChEMBL: CHEMBL455407 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 120.0 nMAFDSI-METABOLOMICS-967
ChEMBL: CHEMBL509950 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 2070.0 nMAFDSI-METABOLOMICS-969
ChEMBL: CHEMBL455408 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 70.0 nMAFDSI-METABOLOMICS-970
ChEMBL: CHEMBL508050 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 780.0 nMAFDSI-METABOLOMICS-971
ChEMBL: CHEMBL453377 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 21100.0 nMAFDSI-METABOLOMICS-973
ChEMBL: CHEMBL454166 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 810.0 nMAFDSI-METABOLOMICS-975
ChEMBL: CHEMBL316185 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10000.0 nMAFDSI-METABOLOMICS-977
ChEMBL: CHEMBL90164 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 11.0 nMAFDSI-METABOLOMICS-979
ChEMBL: CHEMBL176987 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 977.24 nMAFDSI-METABOLOMICS-1030
ChEMBL: CHEMBL87901 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 60.0 nMAFDSI-METABOLOMICS-980
ChEMBL: CHEMBL313197 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 24.0 nMAFDSI-METABOLOMICS-982
ChEMBL: CHEMBL455407 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 120.0 nMAFDSI-METABOLOMICS-968
ChEMBL: CHEMBL509950 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 2070.0 nMAFDSI-METABOLOMICS-972
ChEMBL: CHEMBL453377 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 21100.0 nMAFDSI-METABOLOMICS-974
ChEMBL: CHEMBL454166 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; EC50 810.0 nMAFDSI-METABOLOMICS-976
ChEMBL: CHEMBL90164 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 11.0 nMAFDSI-METABOLOMICS-978
ChEMBL: TRIMETHOPRIM (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 194.98 nMAFDSI-METABOLOMICS-1021
ChEMBL: CHEMBL87901 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 60.0 nMAFDSI-METABOLOMICS-981
ChEMBL: CHEMBL313197 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 24.0 nMAFDSI-METABOLOMICS-983
ChEMBL: CHEMBL86578 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 93.0 nMAFDSI-METABOLOMICS-985
ChEMBL: CHEMBL313561 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 130.0 nMAFDSI-METABOLOMICS-987
ChEMBL: CHEMBL89381 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10000.0 nMAFDSI-METABOLOMICS-988
ChEMBL: CHEMBL87202 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-990
ChEMBL: CHEMBL87954 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 135.0 nMAFDSI-METABOLOMICS-993
ChEMBL: CHEMBL327772 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3.5 nMAFDSI-METABOLOMICS-994
ChEMBL: CHEMBL115251 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 9.0 %AFDSI-METABOLOMICS-996
ChEMBL: CHEMBL313561 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 130.0 nMAFDSI-METABOLOMICS-986
ChEMBL: CHEMBL89381 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10000.0 nMAFDSI-METABOLOMICS-989
ChEMBL: CHEMBL87202 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 10.0 nMAFDSI-METABOLOMICS-991
ChEMBL: CHEMBL87954 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 135.0 nMAFDSI-METABOLOMICS-992
ChEMBL: CHEMBL327772 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; IC50 3.5 nMAFDSI-METABOLOMICS-995
ChEMBL: CHEMBL115251 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 9.0 %AFDSI-METABOLOMICS-997
ChEMBL: CHEMBL251949 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 80.5 %AFDSI-METABOLOMICS-999
ChEMBL: CHEMBL112645 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 14.8 %AFDSI-METABOLOMICS-1000
ChEMBL: CHEMBL114647 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 32.7 %AFDSI-METABOLOMICS-1003
ChEMBL: CHEMBL324551 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 15.6 %AFDSI-METABOLOMICS-1004
ChEMBL: CHEMBL326887 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 20.9 %AFDSI-METABOLOMICS-1006
ChEMBL: CHEMBL115025 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 8.0 %AFDSI-METABOLOMICS-1008
ChEMBL: CHEMBL326854 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 70.3 %AFDSI-METABOLOMICS-1010
ChEMBL: CHEMBL251949 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 80.5 %AFDSI-METABOLOMICS-998
ChEMBL: CHEMBL112645 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 14.8 %AFDSI-METABOLOMICS-1001
ChEMBL: CHEMBL114647 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 32.7 %AFDSI-METABOLOMICS-1002
ChEMBL: CHEMBL324551 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 15.6 %AFDSI-METABOLOMICS-1005
ChEMBL: CHEMBL326887 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 20.9 %AFDSI-METABOLOMICS-1007
ChEMBL: CHEMBL115025 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 8.0 %AFDSI-METABOLOMICS-1009
ChEMBL: CHEMBL326854 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 70.3 %AFDSI-METABOLOMICS-1011
ChEMBL: CHEMBL114695 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 77.0 %AFDSI-METABOLOMICS-1013
ChEMBL: CHEMBL115159 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 66.8 %AFDSI-METABOLOMICS-1015
ChEMBL: CHEMBL33697 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 22.39 nMAFDSI-METABOLOMICS-1018
ChEMBL: CHEMBL281618 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 776.25 nMAFDSI-METABOLOMICS-1020
ChEMBL: TRIMETHOPRIM (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 194.98 nMAFDSI-METABOLOMICS-1022
ChEMBL: CHEMBL20975 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 42.66 nMAFDSI-METABOLOMICS-1024
ChEMBL: CHEMBL20587 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 218.78 nMAFDSI-METABOLOMICS-1026
ChEMBL: CHEMBL6742 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 1659.59 nMAFDSI-METABOLOMICS-1028
ChEMBL: CHEMBL114695 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 77.0 %AFDSI-METABOLOMICS-1012
ChEMBL: CHEMBL115159 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Inhibition 66.8 %AFDSI-METABOLOMICS-1014
ChEMBL: CHEMBL7130 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 93.33 nMAFDSI-METABOLOMICS-1016
ChEMBL: CHEMBL33697 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 22.39 nMAFDSI-METABOLOMICS-1017
ChEMBL: CHEMBL281618 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 776.25 nMAFDSI-METABOLOMICS-1019
ChEMBL: CHEMBL20975 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 42.66 nMAFDSI-METABOLOMICS-1023
ChEMBL: CHEMBL20587 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 218.78 nMAFDSI-METABOLOMICS-1025
ChEMBL: CHEMBL6742 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 1659.59 nMAFDSI-METABOLOMICS-1027
ChEMBL: CHEMBL176987 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 977.24 nMAFDSI-METABOLOMICS-1029
ChEMBL: CHEMBL21254 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 302.0 nMAFDSI-METABOLOMICS-1031
ChEMBL: CHEMBL20466 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 134.9 nMAFDSI-METABOLOMICS-1033
ChEMBL: CHEMBL21254 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 302.0 nMAFDSI-METABOLOMICS-1032
ChEMBL: CHEMBL20466 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; Ki 134.9 nMAFDSI-METABOLOMICS-1034